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Edited by Francesc PosasAbstract XNP/ATRX, a causative gene of X-linked a-thalasse-
mia/mental retardation syndrome, encodes an SNF2 family
ATPase/helicase protein. To better understand the role of
XNP/ATRX in development, we isolated and characterized a
Drosophila XNP/ATRX homolog, dXNP, which contains highly
conserved SNF2 and helicase domains. Ectopically expressed
dXNP induced strong apoptosis in the developing eye and wing,
but did not aﬀect cell cycle progression or the expression of wing-
less and engrailed, essential regulators of development. The
dXNP-induced apoptosis was strongly suppressed by DJNKK/
hemipterous mutation, and dXNP increased JNK activity.
Taken together, these results suggest that dXNP regulates apop-
tosis via JNK activation.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Mutations in XNP/ATRX cause several X-linked mental
retardation syndromes that also feature facial dysmorphism,
urogenital defects, and a-thalassemia [1,2]. In males, somatic
mutations of this gene also cause a-thalassemia myelodysplasia
syndrome (OMIM 300448) [3]. Female carriers, however, are
physically and intellectually normal [1].
XNP/ATRX, which was ﬁrst isolated as a gene poten-
tially coding for a nuclear protein [4], encodes a member of
the SNF2 family proteins with ATPase and helicase domains
that are most similar to those of RAD54 [5,6]. XNP/ATRX
is also known to associate with nuclear matrix and chroma-
tin [7,8]. Recently, it was shown that XNP/ATRX forms
a complex, which displays ATP-dependent chromatinAbbreviations: ATRX, a-thalassemia X-linked mental retardation;
JNK, Jun-N-terminal kinase; XNP, X-linked nuclear protein
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doi:10.1016/j.febslet.2007.05.005remodeling activities including triple-helix DNA displace-
ment and alteration of mononucleosome disruption pat-
terns [9], and was found to be a part of the NuRD complex
[10].
A series of studies have shown that XNP/ATRX is involved
in diverse cellular processes, including DNA methylation, tran-
scription, cell cycle, and apoptosis [11–14]. The methylation
pattern of several highly repeated sequences changes in the
genomic DNA of ATR-X syndrome patients’ lymphocytes
[11]. The fusion protein of XNP/ATRX and GAL4 DNA
binding domain strongly inhibits the expression of thymidine
kinase promoter driven luciferase [12]. BrdU incorporation
and histone H3 phsophorylation, which are cell cycle markers
for S phase and G2/M phase, respectively, are altered in trans-
genic XNP/ATRX embryos [13]. In addition, loss of XNP/
ATRX protein by conditional gene-targeting in mice causes
a 12-fold increase in neuronal apoptosis during early stages
of corticogenesis, and resulted in hypocellularity in the mutant
brain [14].
Despite the XNP/ATRX-related cellular processes have been
revealed, their molecular mechanisms and the role in develop-
ment are still remain to be determined. Here, to uncover the
function of XNP/ATRX in developing tissues, we isolated
and characterized Drosophila XNP/ATRX homologue (dXNP).
The ectopically expressed dXNP by UAS-GAL4 system in
developing tissues induced apoptosis in a cell autono-
mous manner. Genetic and biochemical analysis showed that
the dXNP-induced apoptosis is mediated by activation of
JNK.2. Materials and methods
2.1. Drosophila strains
Glass multimer reporter (GMR)-GAL4, patched (ptc)-GAL4, apterous
(ap)-GAL4, UAS-DIAP1, UAS-puckered, UAS-lacZ, wingless (wg)-
lacZ, engrailed (en)-lacZ, dXNP1 (EP635), and dXNP2 (UY3132) were
obtained from the Bloomington Drosophila Stock Center. MS1096-
GAL4 and hemipterous1 were gifts from Dr. M. Freeman (MRC Lab-
oratory of Molecular Biology, UK) and Dr. S. Noselli (CNRS,
France), respectively.2.2. Ectopic gene expression using UAS-GAL4 system
To ectopically overexpress dXNP, we used the modular misexpres-
sion system based on a P-element vector carrying a GAL4-regulated
promoter [15–17]. In dXNP1 and dXNP2 lines, the P-elements are in-
serted in the ﬂanking region of dXNP so that GAL4-dependent tran-
scription begins within the P-element and extends out into theblished by Elsevier B.V. All rights reserved.
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ted dXNP expression in the developing eye, the whole developing wing
(strongly in the dorsal part), the border of anterior/posterior compart-
ment of wing, and the dorsal compartment of wing, respectively.
External eye morphologies were observed by scanning electron
microscopy (Korea Basic Science Institute, Korea).Fig. 1. Drosophila XNP and its mutants. (A) Comparison of Drosophila X
Drosophila and Human XNP. Abbreviations: SNF2 N-terminal domain (S
Northern blot analysis of dXNP transcripts during Drosophila development.
third instar larva; P, pupa; M, adult male; F, adult female. (C) Real time RT-
Upper panel shows the relative transcript levels determined by real time RT-P
the body (**P < 0.01 vs. body by paired Student’s t-test; n = 3). Lower pane
RT-PCR products were resolved on 1% agarose gels and visualized by ethi
drawn as boxes and coding regions are highlighted in black. The P-elemen
expression of dXNP using UAS-GAL4 system. (E) Determination of express
dXNP alleles using RT-PCR method. Actin was used as an internal control
GAL4/+), GMR > dXNP1 (GMR-GAL4/+; dXNP1/+), and GMR > dXNP2 (G
the induction of dXNP mRNA expression in the eye imaginal discs of GMR-G
GAL4/+, F) or GMR > dXNP (GMR-GAL4/+; dXNP2/+, G).2.3. Acridine orange (AO) staining and BrdU labeling experiment
Eye and wing imaginal discs of stage L3 larvae were dissected in
phosphate-buﬀered saline (PBS). The discs were then incubated for
5 min in 1.6 · 106 M solution of acridine orange (Aldrich, USA),
and rinsed brieﬂy in PBS. The samples were examined under an Axiop-
hot2 ﬂuorescent microscope (Carl Zeiss, Germany).NP with its human counterpart. Protein domains conserved between
NF2_N) and helicase superfamily C-terminal domain (HELICc). (B)
18S rRNA was used as a loading control (lower panel). E, embryo; L,
PCR analysis of dXNP transcripts in the body and head of Drosophila.
CR analysis, normalized with Actin, and expressed as mean ± S.E.% of
l shows the representative picture for the RT-PCR products of dXNP.
dium bromide staining. (D) Genomic structures of dXNP. Exons are
t insertion sites of dXNP1 and dXNP2 are indicated. (E–G) Ectopic
ion levels of dXNP transcript in the eye imaginal discs of GAL4 driven
(lower panel). The genotypes of the samples are GMR-GAL4 (GMR-
MR-GAL4/+; dXNP2/+). (F,G) RNA in situ hybridization shows that
AL4 driven dXNP alleles. Samples were prepared from control (GMR-
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inal discs were performed using the in situ cell proliferation kit (Roche,
Germany) according to the manufacturer’s protocol.2.4. RT-PCR, RNA in situ hybridizations, and Northern blot analysis
Total RNAs from ﬂies were isolated by TRIZOL-bromo-chloropro-
pane protocol. For RT-PCR, one microgram of RNA templates were
reverse-transcribed with 200 U of Moloney murine leukemia virus
(MMLV) reverse transcriptase (Promega, WI) using manufacturer’s
instructions. RT-PCR was performed using the following primer pairs:
dXNP (5 0ATGGGAAAGAAAAACCCCAACG30 for 5 0 and 5 0TTG-
CGACTTTTGCGAGCCG3 0 for 3 0), Actin (5 0TTAGCTCAGCCT-
CGCCACTTGCG3 0 for 5 0 and 5 0GAGCACAGCCTGGATGGCC3 0
for 3 0), hep (5 0GATTGCAGAAGTGCGACAAA3 0 for 5 0 and
5 0GGCTTCTTGGACAGCTTGAG3 0 for 3 0), bsk (5 0AAATGC-
TCGCCACTTTGAGT3 0 for 5 0 and 5 0TGGCTGTAACCGTTG-
CATAA30 for 3 0), DJun (5 0ACACACCCGATTTGGAGAAG3 0 for
5 0 and 5 0TGATGAATAAATAAGTTTAAGGCGTA3 0 for 3 0), and
Dfos (5 0CAGGACACGACCGATACTT3 0 for 5 0 and 5 0ATT-
TGAGGTATTCGCGTTGC3 0 for 3 0). RT products were ampliﬁed
28 times by PCR.
In situ hybridization and Northern blot analysis was performed
using standard method using the probe made from the PCR product
that corresponds to the 3 0 region of the dXNP ampliﬁed with the prim-
ers (5 0TTCTCATGGCTCCTCCAGCC3 0 for 5 0 and 5 0TCATCCTC-
GTCGGTTTCGTC30 for 3 0).2.5. Real time RT-PCR
A 2 ll aliquot of each RT sample of head and body was subjected to
real time PCR in a 20 ll reaction mixture containing 4 mM MgCl2,
10 pmol of upstream and downstream primers and 2 ll of 10· Light-Fig. 2. The eﬀect of dXNP overexpression in developing tissues. Scanning e
wing (D–L) resulted from overexpression of dXNP gene are shown. Asteris
genotypes of the samples are (A) GMR-GAL4/+, (B) GMR-GAL4/+; dXNP1
(E,H) MS1096-GAL4/Y; dXNP1/+, (F,I) MS1096-GAL4/Y; dXNP2/+, (J) ptcCycler FastStrart DNA Master SYBR Green 1 (Roche, Germany).
Data were analyzed with LightCycler Software version 3.5. Same prim-
ers were used as conventional RT-PCR.
2.6. Immunohistochemistry and X-gal staining
Drosophila eye or wing imaginal discs were dissected and ﬁxed in 4%
paraformaldehyde in PBS and then washed with PBT (PBS + 0.1%
Tween 20) and blocked in PBT with 2% Normal Goat Serum. The
discs were incubated overnight with rabbit anti-active-Drice antibody
(1:200) [18], rabbit anti-phospho-JNK antibody (Promega, 1:200) or
rabbit anti-phospho-histone 3 antibody (Promega, 1:200) and then
washed in PBT and subsequently further incubated for 1 h at room
temperature in FITC or rhodamine-labeled goat anti-rabbit IgG
(H + L) secondary antibody (1:200 in PBT). The samples were ob-
served by a Axiophot2 ﬂuorescent microscope (Carl Zeiss, Germany).
For 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-Gal)
staining, eye and wing imaginal discs were ﬁxed in 4% formaldehyde
in PBS for 4 min, washed and then incubated in standard X-Gal stain-
ing solution [4.9 mM X-Gal, 3.1 mM K4Fe(CN)6, 3.1 mM K3Fe(CN)6,
1 mM MgCl2, 150 mM NaCl, 10 mM Na2HPO4, 10 mM NaH2PO4,
0.3% Triton X-100] for 30 min at 37 C before observation.3. Results
3.1. Drosophila XNP and its mutants
The dXNP gene, which corresponds to the Berkeley Dro-
sophila Genome Project annotated sequence CG4548, was iso-
lated by PCR-based cloning. The conceptually translated
dXNP protein (1311 amino acids) contains the characteristiclectron micrographs of the external eyes (A–C) and the phenotypes of
ks in (K,L) indicate reduced distance between L3 and L4 veins. The
/dXNP1, (C) GMR-GAL4/+; dXNP2/dXNP2, (D,G) MS1096-GAL4/Y,
-GAL4/+, (K) ptc-GAL4/+; dXNP1/+, and (L) ptc-GAL4/+; dXNP2/+.
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case superfamily C-terminal domain (HELICc) (Fig. 1A). The
C-terminal region of dXNP, which contains these domains,
shows 66% homology (48% identity) to the human counter-
part. As these domains have been known to be important in
chromatin remodeling, it is very likely that dXNP may func-
tion as a chromatin remodeling factor just as mammalian
XNP/ATRX. Consistent with the sequence results, we detected
a single 4.0 kb-transcript of dXNP in all developmental
stages from Northern blot analysis (Fig. 1B). Real time RT-
PCR showed that dXNP is expressed in the whole body, andFig. 3. Induction of apoptosis by expression of dXNP. AO stainings of eye (A
(D) and wing (H,L) imaginal discs are shown. The genotypes of the samples a
+; dXNP2/+, (D) GMR-GAL4/UAS-lacZ, (E) MS1096-GAL4/Y, (F) MS109
GAL4/Y; +/UAS-lacZ, (I) ptc-GAL4/+, (J) ptc-GAL4/+; dXNP1/+, (K) pt
phenotypes caused by ectopic expression of dXNP in the developing eye can b
GAL4/+; dXNP1/+, (O) GMR-GAL4/+; dXNP1/+; UAS-DIAP1/+. (P,Q) Ant
(P) and GMR-GAL4/+; dXNP2/+ (Q).its expression is elevated approximately 2-fold in the head
compared with that of the body (220 ± 10.9% of the body,
p < 0.01) (Fig. 1C), implying that dXNP may play an impor-
tant role in the head.
With the help of the Berkeley Drosophila Genome Project,
we found two P-element insertion lines, dXNP1 and dXNP2,
which contain P-elements in either the 5 0 upstream or ﬁrst exon
of the dXNP gene (Fig. 1D). The directions of the P-elements
are oriented to induce gene expression, implying that these mu-
tants can be used to study the gain-of-function of dXNP [16].
As expected, strong expression of dXNP was observed in the–C) and wing (E–G and I–K) imaginal discs, and X-gal stainings of eye
re (A) GMR-GAL4/+, (B) GMR-GAL4/+; dXNP1/+, (C) GMR-GAL4/
6-GAL4/Y; dXNP1/+, (G) MS1096-GAL4/Y; dXNP2/+, (H) MS1096-
c-GAL4/+; dXNP2/+, and (L) ptc-GAL4/UAS-lacZ. (M–O) The eye
e suppressed by coexpression of DIAP1. (M) GMR-GAL4/+, (N)GMR-
i-active Drice antibody staining of eye imaginal discs of GMR-GAL4/+
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GMR-GAL4 driver by RT-PCR (Fig. 1E) and RNA in situ
hybridization (Fig. 1F and G).3.2. dXNP induces apoptosis
To verify the function of dXNP in Drosophila development,
we examined the eﬀect of overexpression of dXNP on develop-
ing tissues using the UAS-GAL4 system. Overexpression of
dXNP in the developing eye under the control of GMR-
GAL4 destroyed all ommatidia (Fig. 2A–C). In addition, we
examined the eﬀect of overexpression of dXNP in a speciﬁc
compartment of the wing. When dXNP is ectopically overex-
pressed in the entire wing pouch with MS1096-GAL4 driver,
the wings were rumpled and diminished (Fig. 2D–I). And,
the ectopically expressed dXNP in the border of anterior/pos-
terior compartment of wing by ptc-GAL4 resulted in a reduc-
tion of the distance between L3 and L4 veins (Fig. 2J–L).
These results suggest that dXNP is essential for proper tissue
growth during development.
As dXNP overexpression reduces the compartment size of
wing, we tested whether overexpression of dXNP causes apop-
tosis by acridine orange (AO) staining. As expected, we found
strong staining signals in all dXNP overexpressed tissues
(Fig. 3A–C, E–G, and I–K). The AO staining patterns are
found in the region showing GAL4-driven gene expression,
which is reported by lacZ expression (Fig. 3D, H, and L), sug-
gesting that dXNP induced apoptosis in a cell autonomous
manner. Furthermore, dXNP-induced destruction of the eye
was almost completely inhibited by coexpression of Drosophila
inhibitor of apoptosis protein 1 (DIAP1) (Fig. 3M–O), suggest-
ing that the apoptosis induced by dXNP is mediated by caspase
activation. Supporting this idea, we found strong activation of
Drice, an essential caspase of Drosophila [18], in the eye imag-
inal disc of dXNP over-expressed ﬂy (Fig. 3Q) but not in the
control ﬂy (Fig. 3P).Fig. 4. dXNP does not aﬀect cell cycle and expression of develop-
mental regulators. Cell cycle was determined by anti-phospho-histone
H3 antibody staining (A,B) or BrdU incorporation analysis (C,D), and
transcriptional level of compartment determining gene was determined
by X-gal staining (E–H). (A,C)MS1096-GAL4/Y, (B) MS1096-GAL4/
Y; dXNP2/+, (D) MS1096-GAL4/Y; dXNP1/+, (E) MS1096-GAL4/Y;
wg-lacZ/+, (F) MS1096-GAL4/Y; wg-lacZ/+; dXNP1/+, (G)MS1096-
GAL4/Y; en-lacZ/+, (H) MS1096-GAL4/Y; en-lacZ/+; dXNP1/+.3.3. dXNP does not aﬀect the cell diﬀerentiation and cycle
The reduction of tissue compartment also can be a result of
defective cell cycle or gene expression. Therefore, we tested
whether overexpressed dXNP cause impairment of these cellu-
lar processes. However, there was no diﬀerence between the
control and dXNP overexpressed tissues in antibody staining
for phospho-Histone H3 (Fig. 4A and B), a marker for mitosis,
or incorporation of BrdU, a marker for S phase (Fig. 4C and
D). These results imply that cell cycle is not aﬀected by dXNP
overexpression. Next, we examined whether the expression of
genes which are essential for development is altered by elevated
dXNP level. To test this possibility, we checked the expression
of two compartment determining factors, wingless and en-
grailed, in dXNP-overexpressed wing discs using reporter gene
system. As shown in Fig. 4E–H, we did not ﬁnd any diﬀerence
in the expression level of these genes in dXNP-overexpressed
tissues, implying that dXNP overexpression do not aﬀect these
gene expression as well as cell cycle.3.4. dXNP induces apoptosis through JNK signaling pathway
As activation of the JNK signaling pathway is frequently
correlated with induction of apoptosis, and chromatin remod-
eling proteins has been implicated in the JNK-induced apopto-
sis [19], we tested whether JNK signaling pathway mediates
dXNP-induced apoptosis. First, we examined the genetic inter-action between hep1, a Drosophila JNKK, and dXNP. As de-
scribed previously, overexpressed dXNP destroys ommatidia
of compound eye (Fig. 5B and E), while hep1, a hypomorphic
mutant of hep, male exhibits normal compound eye (Fig. 5A
and D). However, interestingly, the dXNP-induced destruction
Fig. 5. dXNP induces apoptosis through the activation of JNK signaling pathway. Scanning electron micrographs of the external eyes (A–F), and AO
staining (G-I) and anti-phospho-JNK antibody staining (J,K) of the eye imaginal discs are shown. (A, D, and G) hep1/Y (B, E, and H) GMR-GAL4/+;
dXNP2/+, (C, F, and I) hep1/Y; GMR-GAL4/+; dXNP2/+, (J) GMR-GAL4/+, (K) GMR-GAL4/+; dXNP2/dXNP2. (L) Real time RT-PCR analysis of
Chic andPuc transcripts in the heads ofGMR-GAL4/+ (GMR) andGMR-GAL4/+; dXNP2/+ (X2) ﬂies. Upper panel shows the relative transcript levels
determined by real time RT-PCR analysis, normalized with Actin, and expressed as means ± S.E.% of the heads of GMR-GAL4/+ (*P < 0.05 and
**P < 0.01 vs. body by paired Student’s t-test; n = 3). Lower panel shows the representative picture for the RT-PCR products of Chic, Puc and Actin.
RT-PCR products were resolved on 1% agarose gels and visualized by ethidium bromide staining. (M) Determination of expression levels of the
components of JNK signaling pathway in the eye imaginal discs using RT-PCR. The genotypes of the samples are GMR-GAL4 (GMR-GAL4/+),
GMR > dXNP1 (GMR-GAL4/+; dXNP1/+), and GMR > dXNP2 (GMR-GAL4/+; dXNP2/+). Actin was used as an internal control (lower panels).
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mutation (Fig. 5C and F). Furthermore, as shown in
Fig. 5G-I, the dXNP-induced apoptosis was also inhibited by
hep1, suggesting that JNK signaling pathway acts as a vital
downstream eﬀector of dXNP in the regulation of apoptosis.
Consistent with these results, we also observed that puckered,
a negative regulator of JNK, suppressed the dXNP-induced
wing defect (Fig. S1). In addition, we found that overexpres-
sion of dXNP increases phosphorylation of JNK in both eye
(Fig. 5J and K) and wing (Fig. S2) imaginal discs, and the
expression of direct targets of JNK signaling pathway such
as chickadee (Chic) and puckered (Puc) (Fig. 5L). The expres-
sions of Chic and Puc were increased 1.8-fold (179 ± 29.8%
of the WT, p < 0.05, n = 3) and 2.2-fold (224 ± 14.6% of the
WT, p < 0.01, n = 3), respectively, in the dXNP overexpressed
samples. These results suggest that dXNP regulates the JNK
signaling pathway.
Because XNP has been known as a chromatin remodeling
factor, we tested whether dXNP increases the activity of
JNK signaling pathway by controlling transcription of its com-
ponents. To do this, the transcript levels of bsk, hep, Dfos, and
DJun were measured by quantitative RT-PCR in the eye discs
of the GMR-GAL4 controls and dXNP overexpression ﬂies.
However, as shown in Fig. 5M, their transcript levels were
not altered by overexpression of dXNP, implying that activa-
tion of the JNK signaling pathway is not resulted from an in-
crease in the transcriptional level of signaling components but
probably by the post-transcriptional regulation, such as phos-
phorylation.4. Discussion
In the present study, we have isolated and characterized
Drosophila XNP (dXNP). Overexpression of dXNP induced
strong apoptosis without aﬀecting cell cycle and the expression
level of essential regulators of development. Co-expression of
DIAP1 suppressed dXNP-induced rough eye phenotype
(Fig. 3M–O). As it has been reported that DIAP1 degrades
two proteins, Drosophila caspase DRONC [20] and TRAF1
[21] as its E3 substrate, our result suggest that the caspase cas-
cade is implicated in the apoptosis induced by dXNP. Support-
ing this idea, Drice, a downstream caspase of DRONC [22],
was activated in dXNP-overexpressing tissues (Fig. 3Q). De-
spite the detailed mechanism by which XNP/ATRX involved
in apoptosis is unclear, our study clearly showed that the apop-
tosis induced by dXNP is mediated by caspase cascade. It was
interesting to note that XNP/ATRX is localized in promyelo-
cytic leukemia (PML) nuclear bodies [23], which have been
implicated in apoptosis and senescence [24]. Moreover, the
accumulated XNP/ATRX at PML nuclear bodies interacts
with Daxx, a multifunctional apoptosis-related protein
[23,25], and strong apoptosis was observed in the XNP/
ATRX-null mice [14], implying that XNP/ATRX is a potent
regulator of apoptosis. Since, as a chromatin remodeling fac-
tor, XNP has been associated with DNA methylation and
transcription [11,13], it is possible that dXNP regulates apop-
tosis through direct control of transcription of proapoptotic
factors. However, our study argues that dXNP induces apop-
tosis by activating JNK signaling pathway. dXNP-induced
apoptosis was almost completely suppressed by hep/DJNKK
mutation, suggesting that the apoptosis might be resulted fromthe activation of JNK signaling pathway. Moreover, we also
found that overexpressed dXNP increases phosphorylation of
JNK (Fig. 5K) and the expression of direct targets of JNK
pathway (Fig. 5L). These results demonstrate that dXNP reg-
ulates apoptosis via regulating the JNK signaling pathway
rather than via direct regulation of the transcription of apop-
totic factors.
Then, how dXNP can activate JNK? One possible scenario
is that dXNP activates JNK by controlling the transcription
of upstream regulator of JNK. Although we showed that the
transcriptional level of hep/DJNKK is not altered by dXNP
overexpression, we can not exclude the possibility that the
transcription of other upstream regulator(s) of JNK signaling
pathway is changed. Further study to ﬁnd dXNP targets will
determine this possibility. Alternatively, other interesting sce-
nario is that Daxx can mediate the dXNP-induced JNK activa-
tion and apoptosis. Recently, it has been reported that
Ras-association domain family 1C (RASSF1C), a binding
partner of Daxx, is released from the nucleus to cytoplasm
and activates JNK signaling pathway, when Daxx is degraded
in response to DNA damage [26]. Because Daxx associates
with XNP or RASSF1C in PML nuclear bodies [9,26], overex-
pression of XNP may abrogate the balance between Daxx-
XNP and Daxx-RASSF1C complexes and increase free
RASSF1Cs which, in turn, activate the JNK signaling path-
way. Since Drosophila RASSF homolog has been identiﬁed
and characterized recently [27], it may be interesting to test
whether Daxx and RASSF are involved in the dXNP-induced
JNK activation and apoptosis.
In summary, we have provided genetic and histochemical
evidences that dXNP controls apoptosis in a JNK-dependent
manner, which may explain the underlying mechanism of some
symptoms of ATR-X syndrome, such as mental retardation. In
addition, we here provide evidence for the ﬁrst time that
dXNP, which was previously known as a chromatin remo-
deler, could also play a role as a signal transducer. Elucidating
the molecular mechanism through which dXNP regulates JNK
signaling and apoptosis might be helpful to understand the
developmental role of XNP and this complex disorder.
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